These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4028283)

  • 41. Short term therapy for uncomplicated urinary tract infection today. Clinical outcome upholds the theories.
    Lobel B
    Int J Antimicrob Agents; 2003 Oct; 22 Suppl 2():85-7. PubMed ID: 14527777
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prospective double-blind controlled clinical study of sisomicin versus tobramycin.
    Schieker KR; Hofmann HF
    Pharmatherapeutica; 1981; 2(8):499-503. PubMed ID: 7019928
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fosfomycin in paediatric cancer patients: a feasible alternative to glycopeptides?
    Hepping N; Simon A
    Int J Antimicrob Agents; 2009 Apr; 33(4):389. PubMed ID: 19097756
    [No Abstract]   [Full Text] [Related]  

  • 44. [Fosfomycin in a hematology department].
    Dinelli CA; Montrasio PL; Tansini G
    Minerva Med; 1978 Dec; 69(59):4111-4. PubMed ID: 740308
    [No Abstract]   [Full Text] [Related]  

  • 45. Onset of symptom resolution in adults with acute bacterial rhinosinusitis treated with a single dose of azithromycin extended release compared with 10 days of levofloxacin: a retrospective analysis of a randomized, double-blind, double-dummy trial.
    Marple BF; Roberts CS; de Caprariis PJ; Reisman A
    Clin Ther; 2007 Dec; 29(12):2690-8. PubMed ID: 18201585
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Double-blind comparison of L-keflex and cephalexin (Keflex) in dental infections (author's transl)].
    Horii M; Morinaga T; Shimada S; Takeuchi T; Yamanaka H; Nishimura T; Noshi Y; Okada T; Sasaki T; Ikeda S; Takada S; Iizuka O; Kimura J; Sagara S; Inada Y; Nishioka Y; Kimata M
    Jpn J Antibiot; 1980 Nov; 33(11):1194-214. PubMed ID: 7017189
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Fosfomycin--a new antibiotic in rhinootolaryngology].
    Stammberger H
    HNO; 1983 Dec; 31(12):436-9. PubMed ID: 6662741
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Short-course therapy of acute bacterial exacerbation of chronic bronchitis: a double-blind, randomized, multicenter comparison of extended-release versus immediate-release clarithromycin.
    Nalepa P; Dobryniewska M; Busman T; Notario G
    Curr Med Res Opin; 2003; 19(5):411-20. PubMed ID: 13678478
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative treatment trial of augmentin versus cefaclor for acute otitis media with effusion.
    Odio CM; Kusmiesz H; Shelton S; Nelson JD
    Pediatrics; 1985 May; 75(5):819-26. PubMed ID: 4039433
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Potential of old-generation antibiotics to address current need for new antibiotics.
    Falagas ME; Grammatikos AP; Michalopoulos A
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):593-600. PubMed ID: 18847400
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Fosfomycin, co-trimoxazole and nitrofurantoin in the treatment of recurrent uncomplicated urinary tract infections in type 2 diabetes mellitus].
    Ruxer J; Mozdzan M; Loba J; Markuszewski L
    Wiad Lek; 2007; 60(5-6):235-40. PubMed ID: 17966887
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fosfomycin in infantile acute gastroenteritis.
    Brines J; Escribano A; Bori JV; Colomer J
    Chemotherapy; 1977; 23 Suppl 1():304-9. PubMed ID: 832529
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Tolerance and margin of safety of cephalexin used in the hospital].
    Lippi M; Taglieri G
    Clin Ter; 1978 Mar; 84(6):593-618. PubMed ID: 348385
    [No Abstract]   [Full Text] [Related]  

  • 54. [Efficiency of systemic prophylatic antibiotics in the surgical removal of lower widsom teeth].
    Osborn JF; Jaques WA; Thalmann R; Spiessl B
    SSO Schweiz Monatsschr Zahnheilkd; 1979 May; 89(5):458-66. PubMed ID: 293045
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Editorial: Usage of cephalexin and other new antimicrobials.
    Scheife RT; Meade RH; Miller RR
    Am J Hosp Pharm; 1975 Nov; 32(11):1106. PubMed ID: 1190227
    [No Abstract]   [Full Text] [Related]  

  • 56. [Clinical use of fosfomycin in bacterial infections of the oral cavity in childhood].
    Ghezzi F; Zallio F
    Minerva Stomatol; 1985; 34(4):703-6. PubMed ID: 3862951
    [No Abstract]   [Full Text] [Related]  

  • 57. [Fosfomycin: analysis of the antibiotic and its effects in odontostomatologic diseases].
    Palattella G; Massi C; Corbelli V; Palattella E; Pignatelli N
    Clin Ter; 1985 May; 113(3):211-4. PubMed ID: 4017500
    [No Abstract]   [Full Text] [Related]  

  • 58. Cephalexin-induced cholestatic hepatitis.
    Skoog SM; Smyrk TC; Talwalkar JA
    J Clin Gastroenterol; 2004 Oct; 38(9):833. PubMed ID: 15365421
    [No Abstract]   [Full Text] [Related]  

  • 59. Surgical suppurating infections and surgical abdominal infections treated with fosfomycin.
    Gallardo A; Sáez JM; Enriquez G; Cobacho AR; Torronteras R; Recordan C; Del Moral A; Arroyo A; Curiel AG
    Chemotherapy; 1977; 23 Suppl 1():392-8. PubMed ID: 832540
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative study of cephalexin hydrochloride and cephalexin monohydrate in the treatment of skin and soft tissue infections.
    Kumar A; Murray DL; Hanna CB; Kreindler TG; Jacobson KD; Bundy JM; Waxman K; Finnerty EF; Folan DW; Drucker WR
    Antimicrob Agents Chemother; 1988 Jun; 32(6):882-5. PubMed ID: 3046484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.